December 5, 2018 / 2:22 PM / 6 days ago

BRIEF-Icagen Enters Into License & Collaboration Agreement With Roche

Dec 5 (Reuters) - Icagen:

* ICAGEN - ENTERS INTO LICENSE & COLLABORATION AGREEMENT WITH ROCHE TO DEVELOP MOLECULE ION CHANNEL MODULATORS FOR TREATMENT OF NEUROLOGICAL DISORDERS

* ICAGEN - ROCHE WILL MAKE A CASH UPFRONT PAYMENT AND PROVIDE RESEARCH FUNDING TO CO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below